PCR Molecular Testing

Concepts

• birmingham
• pathology services
• mpds
• pcr molecular testing
• molecular pathology diagnostic service
• pcr molecular testing platforms
• rapid molecular testing
• translocation testing
• university hospitals birmingham nhs trust
• lung cancer samples

Location

United Kingdom:

Description

University Hospitals Birmingham NHS Trust are looking at tendering for PCR Molecular Testing Platforms in order to carry out rapid molecular testing.

Total Quantity or Scope

The Molecular Pathology Diagnostic Service (MPDS) at UHB needs to be able to deliver a quick and highly sensitive assessment of RET and MET alterations in lung cancer samples, which is required prior to the prescription of drugs targeting RET and MET. A quick turn around time is required, since lung cancer patients need to be started on the treatment as soon as possible. Lung tumour samples are of small size; there is therefore a need for a highly sensitive technology with a very low rate of failure. MPDS receives at least 350 lung cancer samples every month for MET exon 14 mutation and RET translocation testing; the numbers are likely to increase; the technology therefore needs to be adaptable to the needs. In order to take into account the various clinical circumstances, the technology needs to allow MPDS to perform RET and MET exon 14 alterations within a few hours for selected tumours.

CPV Codes

• 85111800 - Pathology services

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** Due to Issues with the portal the PIN has been republished for an additional week.